Status:

COMPLETED

Discovering the Gene(s) Causing Developmental Dysplasia of the Hip (DDH)

Lead Sponsor:

University of Utah

Conditions:

Hip Dysplasia

Eligibility:

All Genders

7-90 years

Brief Summary

The primary objective of the study is to find the gene(s) responsible for causing DDH. The secondary objective of the study is to determine the mode of genetic transmission of DDH.

Detailed Description

Developmental dysplasia of the hip (DDH), formerly known as Congenital Dislocation of the Hip (CDH) is a relatively common disorder that can lead to early onset arthritis of the hip. It is believed th...

Eligibility Criteria

Inclusion

  • All patients with radiographic and clinical diagnosis of DDH will be included.

Exclusion

  • Other forms of arthritis:
  • osteoarthritis
  • inflammatory arthropathies
  • vascular necrosis

Key Trial Info

Start Date :

January 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2019

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT01193673

Start Date

January 1 2010

End Date

July 1 2019

Last Update

October 23 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Utah Orthopaedic Center

Salt Lake City, Utah, United States, 84108